申请人:Bayer Aktiengesellschaft
公开号:US04559342A1
公开(公告)日:1985-12-17
The invention relates to quinolone carboxylic acids of the formula (I) as defined herein, pharmaceutical compositions containing said quinolone carboxylic acids and the use of said compounds and compositions for treatment of bacterial infection. Also included in the invention are process for the manufacture of the active quinolone carboxylic acids.
该发明涉及到以下定义的式(I)的喹诺酮羧酸,含有该喹诺酮羧酸的药物组合物,以及用于治疗细菌感染的该化合物和组合物的用途。该发明还包括制造活性喹诺酮羧酸的工艺。